Terms: = Sarcomas AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Diagnosis
11 results:
1. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
2. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid Sarcoma of the Breast as Blast Phase of jak2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review.
Pace M; Guadagno E; Russo D; Gencarelli A; Carlea A; Di Spiezio A; Bertuzzi C; Mascolo M; Grimaldi F; Insabato L
Pathobiology; 2023; 90(2):123-130. PubMed ID: 35850113
[TBL] [Abstract] [Full Text] [Related]
4. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract] [Full Text] [Related]
5. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study.
Zhang C; Guo X; Xu Y; Han X; Cai J; Wang X; Wang G
Sao Paulo Med J; 2019; 137(5):423-429. PubMed ID: 31939567
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
[TBL] [Abstract] [Full Text] [Related]
7. Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with
Gröschel S; Bommer M; Hutter B; Budczies J; Bonekamp D; Heining C; Horak P; Fröhlich M; Uhrig S; Hübschmann D; Geörg C; Richter D; Pfarr N; Pfütze K; Wolf S; Schirmacher P; Jäger D; von Kalle C; Brors B; Glimm H; Weichert W; Stenzinger A; Fröhling S
Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001180. PubMed ID: 27900363
[TBL] [Abstract] [Full Text] [Related]
8. Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor.
Novello M; Coli A; Della Pepa GM; Martini M; Doglietto F; De Stefano V; Bellesi S; Pescarmona E; Lauriola L
Neuropathology; 2014 Apr; 34(2):179-84. PubMed ID: 24118374
[TBL] [Abstract] [Full Text] [Related]
9. FLT3 mutations in myeloproliferative neoplasms: the Beaumont experience.
Williams L; Kelley HH; Meng X; Prada A; Crisan D
Diagn Mol Pathol; 2013 Sep; 22(3):156-60. PubMed ID: 23846442
[TBL] [Abstract] [Full Text] [Related]
10. Gene expression profiling of solitary fibrous tumors.
Bertucci F; Bouvier-Labit C; Finetti P; Metellus P; Adelaide J; Mokhtari K; Figarella-Branger D; Decouvelaere AV; Miquel C; Coindre JM; Birnbaum D
PLoS One; 2013; 8(5):e64497. PubMed ID: 23734203
[TBL] [Abstract] [Full Text] [Related]
11. Postsplenectomy sclerosing extramedullary hematopoietic tumor with unexpected good clinical evolution: morphologic, immunohistochemical, and molecular analysis of one case and review of the literature.
Gualco G; Ojopi EB; Chioato L; Cordeiro DL; Negretti F; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):291-5. PubMed ID: 20042850
[TBL] [Abstract] [Full Text] [Related]
